Admission Date:  [**2145-11-16**]       Discharge Date:  [**2145-12-2**]   Service:  MEDICINE, [**Location (un) 259**] FIRM  HISTORY OF PRESENT ILLNESS:  The patient is a 77-year-old female with a history of diverticular bleeding, coronary artery disease, atrial valve replacement on Coumadin, who presented with passing clots per rectum for three days.
She denied taking Coumadin the night before admission.
In the Emergency Room, she was given 1 L of intravenous fluids but no FFP or Vitamin K.  She was hemodynamically stable and transferred to the floor.
Status post atrial valve replacement, St. Jude's valve.
MEDICATIONS ON ADMISSION:  Coumadin 2.5 mg p.o.
q.d., Glyburide 10 mg p.o.
b.i.d., Lopressor 37.5 mg p.o.
t.i.d., Lasix 40 mg p.o.
b.i.d., Captopril 25 mg p.o.
t.i.d., Glucophage 500 mg p.o.
b.i.d., Serevent 2 puffs b.i.d., Zantac 100 mg p.o.
b.i.d., Digoxin 0.125 mg p.o.
q.d., Combivent MDI 2 puffs b.i.d., Lipitor 10 mg p.o.
ALLERGIES:  PENICILLIN CAUSES A RASH.
The patient was treated with protime pump inhibitor while on the Medical Intensive Care Unit, and we returned her to Zantac following discharge.
In the Medical Intensive Care Unit, increasing doses of Lopressor were administered up to 75 mg p.o.
plus supplemental Lopressor given intravenously.
Therefore, she was weaned off of Lopressor and started on a Diltiazem drip.
dose of Cardizem 90 mg p.o.
q.i.d., and following discharge, this was changed to Cardizem CD 360 mg p.o.
We continued the patient's Digoxin and Lipitor.
She was admitted on Captopril 25 mg p.o.
This was treated with Levofloxacin 500 mg p.o.
The last day of her Levofloxacin dose should be [**2145-12-5**].
The patient also had a urinary tract infection which was found to be Enterococcus susceptible to Levofloxacin; therefore, Levofloxacin treated both her pneumonia, as well as her urinary tract infection.
Hematology:  The patient's goal INR is 2.5-3.5 given her atrial valve replacement with a St. Jude's valve, as well as her atrial fibrillation.
The patient was given FFP, as well as Vitamin K to reverse the INR.
Several units of blood were transfused given the patient's low hematocrit and documented coronary artery disease, as well as congestive heart failure.
When the patient was transferred from the Medical Intensive Care Unit to the General Medicine Floor, she was subtherapeutic on her Coumadin, so we treated her with Lovenox 80 mg subcue b.i.d.
q.d., the patient's INR stalled at 2.3; therefore, we increased her Coumadin dose to 3.0 mg q.Monday, Wednesday, and Friday, and 2.5 mg q.Tuesday, Thursday,   Saturday, and Sunday.
She required intubation for several days, following which she was extubated successfully without complications.
She was then treated with nebulized Albuterol and Atrovent and later weaned off of these and treated with her regular metered dose inhalers.
As mentioned, the patient had a pneumonia that was treated with Levofloxacin successfully.
Fluids, electrolytes, and nutrition:  The patient received TPN while she was intubated on the Medical Intensive Care Unit.
This was normal, and the patient did well with liquids and solids.
Endocrine:  The patient had good glucose control with Glyburide, Glucophage, and regular Insulin sliding scale.
DISCHARGE MEDICATIONS:  Cardizem CD 360 mg p.o.
q.d., Lipitor 10 mg p.o.
q.d., Serevent MDI 2 puffs b.i.d., Combivent MDI 2 puffs b.i.d., Zantac 150 mg p.o.
b.i.d., Digoxin 0.125 mg p.o.
q.d., Glucophage 500 mg p.o.
b.i.d., Glyburide 10 mg p.o.
b.i.d., Captopril 12.5 mg p.o.
b.i.d., Coumadin 3.0 mg q.Monday, Wednesday, Friday, 2.5 mg q.Tuesday, Thursday, Saturday, Sunday, once the patient's INR reaches 2.5, this should probably be decreased to 2.5 mg p.o.
q.d., her goal INR is 2.5-3.5, this should be followed closely while she is an outpatient, Lovenox 80 mg subcue b.i.d.
until her INR is therapeutic, Levofloxacin 500 mg p.o.
DISCHARGE INSTRUCTIONS:  Her diet should include thick liquids and solids, and she should advance to full solids as tolerated.
